Graft copolymer polyelectrolyte complexes for drug delivery
View Patent ↗Graft copolymer polyelectrolyte complexes are disclosed for the efficient delivery of anionic, cationic or polyelectrolyte therapeutic agents into biological cells, and for maintaining the biological activity of these molecules while in serum and other aqueous environments are provided. Such complexes comprise (1) an anionic graft copolymer containing an anionic polymer backbone, with pendent carboxylic acid groups and pendant chains containing amphipathic or hydrophilic polymers covalently bonded to a portion of the pendant carboxylic acid groups, (2) one or more anionic, cationic or polyelectrolyte therapeutic agents, and (3) optionally a liposome optionally containing an additional therapeutic agent. Also disclosed are functional nanoparticles containing the complexes.
1. A graft copolymer polyelectrolyte complex comprising:
(1) an anionic graft copolymer comprising:
(i) a backbone comprising a poly(alkylacrylic acid); and
(ii) one or more polyetheramine pendent chains covalently attached to said copolymer backbone as amides of acrylic acid groups, wherein said pendent chains predominantly comprise ethylene oxide repeating units;
wherein said copolymer has a graft density between about 0.1 and about 25 mole percent;
(2) one or more anionic, cationic or polyelectrolyte therapeutic agents; and
(3) optionally, a liposome which optionally comprises a further therapeutic agent;
wherein when said anionic, cationic or polyelectrolyte therapeutic agent is a polynucleotide molecule, said liposome, optionally comprising said further therapeutic agent, is also present; and wherein said pendent chains further comprise one or more ligands that target a microbial biofilm or a planktonic microbe; or said pendent chains further comprise one or more ligands which comprise a phosphonate molecule that targets bone tissue.
2. The complex of claim 1 , wherein the copolymer backbone comprises poly(propyl acrylic acid) or poly(methacrylic acid).
3. The complex of claim 1 , wherein said copolymer has a graft density between about 0.5 and about 5 mole percent.
4. The complex of claim 1 , wherein said liposome is present.
5. The complex of claim 1 , wherein said anionic, cationic or polyelectrolyte therapeutic agent is stabilized toward biological degradation in vivo.
6. A functional nanoparticle comprising the complex of claim 1 , wherein said nanoparticle provides in vivo delivery of the anionic, cationic or polyelectrolyte therapeutic agent.
7. A method of treating a patient in need thereof with a polyelectrolyte therapeutic agent comprising the steps of:
(1) formulating the complex of claim 1 with one or more pharmaceutically acceptable carriers to provide a pharmaceutical composition; and
(2) administering said pharmaceutical composition to said patient in an amount effective to treat said patient.
8. The method of claim 7 , wherein said anionic, cationic or polyelectrolyte therapeutic agent is selected from the group consisting of antibacterial agents, anticancer agents, wound treatment agents and tissue regeneration agents.
9. The method of claim 7 , wherein the administration is via oral, enteral, parenteral or topical delivery.
10. The method of claim 7 , wherein said pharmaceutical composition is selected from the group consisting of injectable aqueous solutions, injectable aqueous dispersions, emulsions, gels, pastes, aerosols, sprays, coatings, hydrogels, topical creams, topical ointments, natural and synthetic polymeric fibers, porous ceramics, polymeric and ceramic composites, and wound treatment compositions.
11. A method of preparing a graft copolymer-polyelectrolyte complex of claim 1 , comprising the steps of:
(1) providing an aqueous mixture of an anionic graft copolymer comprising:
(i) a backbone comprising a poly(alkyl acrylic acid); and
(ii) one or more polyetheramine pendent chains covalently attached to said copolymer backbone as amides of acrylic acid groups, wherein said pendent chains predominantly comprise ethylene oxide repeating units;
wherein said copolymer has a graft density between about 0.1 and about 25 mole percent;
(2) adding one or more polyelectrolytes to form a polyelectrolyte-copolymer mixture;
(3) optionally adding an aqueous mixture containing a liposome which optionally comprises a further therapeutic agent, to form a liposome-containing polyelectrolyte-copolymer mixture; and
(4) allowing said polyelectrolyte-copolymer mixture or said liposome-containing polyelectrolyte-copolymer mixture to self-assemble in the aqueous medium to form said complex, which further forms nanoparticles.
12. A graft copolymer polyelectrolyte complex comprising:
(1) an anionic graft copolymer comprising:
(i) a backbone comprising a poly(alkylacrylic acid); and
(ii) one or more polyetheramine pendent chains covalently attached to said copolymer backbone as amides of acrylic acid groups, wherein said pendent chains predominantly comprise ethylene oxide repeating units;
wherein said copolymer has a graft density between about 0.1 and about 25 mole percent;
(2) one or more anionic, cationic or polyelectrolyte therapeutic agents; and
(3) optionally, a liposome which optionally comprises a further therapeutic agent;
wherein said anionic, cationic or polyelectrolyte therapeutic agent is selected from the group consisting of vancomycin, telavancin, daptomicin, mepivacaine, lidocaine, bupivacaine, benzocaine and procaine.
13. The complex of claim 12 , wherein said anionic, cationic or polyelectrolyte therapeutic agent is daptomicin.
14. The complex of claim 12 , wherein said anionic, cationic or polyelectrolyte therapeutic agent is selected from the group consisting of mepivacaine, lidocaine, bupivacaine, benzocaine and procaine.